ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Mapping 25 years of research on gut microbiota and antibiotic resistance: bibliometric insights and future directions.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveAntibiotic resistance poses a major global public health threat. It compromises human health and increases healthcare burdens. The gut microbiota serves as a critical reservoir for antibiotic resistance genes (ARGs). It plays a pivotal role in the spread and evolution of antibiotic resistance. This study systematically analyzes the literature regarding on antibiotic resistance and gut microbiota from 1999 to 2024. It aims to elucidate global distribution, collaboration patterns, key contributors, current research hotspots, and future directions.
methodsThis study analyzes academic literature from the Web of Science Core Collection (1999-2024). VOSviewer was used to assess countries/regions, institutions, and co-cited journals for clustering and timeline visualizations. CiteSpace was employed to examine authors, co-cited authors, journals, references, and keywords for clustering, timeline visualizations, and burst detection. Additionally, Biblioshiny was used to create a global collaboration map of countries/regions.
resultsThis global analysis included 4,863 articles from 132 countries/regions, over 5,700 institutions, and 26,931 authors. Recent years show a significant increase in publication volume. The study mapped the global distribution and identified key contributing countries, authors, and institutions. Current research hotspots focus on ARGs and immunotherapy. The findings highlight the need to address host-related factors, lifecycle-specific issues, regional research disparities, and antibiotic resistance pressures. Novel therapeutic approaches and their integration with environmental science require further exploration to advance resistance management.
conclusionThis study is the first to use a systematic review to explore trends and emerging hotspots in antibiotic resistance and gut microbiota research. The identification of key contributors, including leading countries, institutions, authors, and journals, providing a foundation for advancing further collaboration and progress. It also highlights underexplored areas and potential future directions through a bibliometric perspective.
Indexed as
Identifiers
41840272What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.